JP2002533430A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533430A5
JP2002533430A5 JP2000590985A JP2000590985A JP2002533430A5 JP 2002533430 A5 JP2002533430 A5 JP 2002533430A5 JP 2000590985 A JP2000590985 A JP 2000590985A JP 2000590985 A JP2000590985 A JP 2000590985A JP 2002533430 A5 JP2002533430 A5 JP 2002533430A5
Authority
JP
Japan
Prior art keywords
formula
compound
embedded image
alkyl
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000590985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533430A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/030748 external-priority patent/WO2000039072A1/en
Publication of JP2002533430A publication Critical patent/JP2002533430A/ja
Publication of JP2002533430A5 publication Critical patent/JP2002533430A5/ja
Pending legal-status Critical Current

Links

JP2000590985A 1998-12-29 1999-12-23 アリールエーテルの調製方法 Pending JP2002533430A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11409298P 1998-12-29 1998-12-29
US60/114,092 1998-12-29
PCT/US1999/030748 WO2000039072A1 (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers

Publications (2)

Publication Number Publication Date
JP2002533430A JP2002533430A (ja) 2002-10-08
JP2002533430A5 true JP2002533430A5 (enExample) 2006-08-17

Family

ID=22353332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590985A Pending JP2002533430A (ja) 1998-12-29 1999-12-23 アリールエーテルの調製方法

Country Status (24)

Country Link
US (1) US6376711B1 (enExample)
EP (2) EP1140788B1 (enExample)
JP (1) JP2002533430A (enExample)
KR (2) KR100616029B1 (enExample)
CN (3) CN1308332C (enExample)
AT (2) ATE430144T1 (enExample)
AU (1) AU764492B2 (enExample)
BR (1) BR9916615A (enExample)
CA (1) CA2349619A1 (enExample)
CO (1) CO5140125A1 (enExample)
DE (2) DE69940833D1 (enExample)
DK (1) DK1140788T3 (enExample)
ES (1) ES2214060T3 (enExample)
HK (1) HK1041688B (enExample)
HU (1) HUP0202144A3 (enExample)
IL (2) IL161840A0 (enExample)
NZ (1) NZ511452A (enExample)
PE (1) PE20001366A1 (enExample)
PT (1) PT1140788E (enExample)
SI (1) SI1140788T1 (enExample)
TR (1) TR200101885T2 (enExample)
TW (1) TWI238155B (enExample)
WO (1) WO2000039072A1 (enExample)
ZA (1) ZA200103532B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
AR030284A1 (es) 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
JP2007523153A (ja) * 2004-02-20 2007-08-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー アリールエーテルの製造方法
WO2005095435A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. プレグナン誘導体の製造方法
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
EA200601798A1 (ru) 2004-04-30 2007-04-27 Уорнер-Ламберт Компани Ллс Замещенные соединения морфолина для лечения расстройств центральной нервной системы
DK2076508T3 (da) 2006-10-18 2011-02-21 Pfizer Prod Inc Biaryl-ether-urinstof-forbindelser
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
CN103804316A (zh) * 2012-11-13 2014-05-21 天津药物研究院 一种(2RS,3RS)-6-[a-(2-乙氧基苯氧基)苄基]吗啉-3-酮(Ⅰ)的制备方法
CN104557936A (zh) * 2015-01-15 2015-04-29 河南科技学院 一种新型手性非环嘌呤核苷类似物的合成方法
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785185A (en) * 1952-08-07 1957-03-12 Union Carbide & Carbon Corp Process for making oxirane compounds from olefins and aldehyde monoperacylates
GB1053972A (enExample) * 1962-08-30 1967-01-04
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane

Similar Documents

Publication Publication Date Title
JP2002533430A5 (enExample)
CN100371314C (zh) 苯甲酰基衍生物和其盐酸盐及其制备方法
CN1173178A (zh) 咪唑并[4,5-c]喹啉胺类
TW198720B (enExample)
JP5604424B2 (ja) アポトーシス促進剤abt−263の調製のための方法
JP2007520434A5 (enExample)
CA2370244C (en) Piperidine derivatives
CN1059516A (zh) 联苯甲腈的制备方法
JP2003519207A5 (enExample)
GB2357761A (en) An intermediate for the preparation of citalopram
JP2010510976A5 (enExample)
CN1279681A (zh) 作为p物质拮抗剂的哌啶基氨基甲基三氟甲基环醚化合物
JP2013520495A5 (enExample)
JP2004529172A5 (enExample)
JP2005502603A5 (enExample)
CN1656101A (zh) 喜树碱20位酯
JP2006518765A5 (enExample)
EP2307392A2 (en) Processes for the synthesis of levocetirizine and intermediates for use therein
JP2003500405A (ja) 1−トリフルオロメチル−4−ヒドロキシ−7−ピペリジニル−アミノメチルクロマン誘導体類
TW200808754A (en) Benzodioxane and benzodioxolane derivatives and uses thereof
CN1025187C (zh) 新的组胺h2-拮抗药中间体的制备方法
US6239296B1 (en) Process for a phenylthiobutyl-isoquinoline and intermediates therefor
US20080096946A1 (en) Process For The Preparation Of Anastrozole
PT92001B (pt) Processo para a preparacao de derivados amina antagonistas dos receptores muscarinicos
CA2047617A1 (en) Process for the preparation of 6-(substitutedaminopropionyl)-derivatives of forskolin